Serres, F., Millan, M., & Sharp, T. (2012). Molecular adaptation to chronic antidepressant treatment: Evidence for a more rapid response to the novel α₂-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine.
Citação do estilo Chicago (17ª ed.)Serres, F., M. Millan, e T. Sharp. Molecular Adaptation to Chronic Antidepressant Treatment: Evidence for a More Rapid Response to the Novel α₂-adrenoceptor Antagonist/5-HT-noradrenaline Reuptake Inhibitor (SNRI), S35966, Compared to the SNRI, Venlafaxine. 2012.
Citação MLA (9ª ed.)Serres, F., et al. Molecular Adaptation to Chronic Antidepressant Treatment: Evidence for a More Rapid Response to the Novel α₂-adrenoceptor Antagonist/5-HT-noradrenaline Reuptake Inhibitor (SNRI), S35966, Compared to the SNRI, Venlafaxine. 2012.